GlassScriptPhysician profile
Henry A Taylor
NPI 1861590754
$1,021.88
in general payments reported to CMS, 2019-2025
14 companies · $209 in 2025
The $209 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $341 · 2020: $161 · 2021: $18.04 · 2022: $127 · 2023: $84.31 · 2024: $82.09 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $375.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $267.38 | 2019-2025 | Grafix Pl, Stravix, Ultrabraid |
| Organogenesis INC. | $150.19 | 2019-2023 | Puraply |
| Stryker Corporation | $139.28 | 2019 | |
| Paratek Pharmaceuticals, INC. | $97.58 | 2022 | |
| Treace Medical Concepts, INC. | $76.47 | 2025 | |
| Djo, LLC | $74.74 | 2020 | |
| Amgen INC. | $64.90 | 2024-2025 | Krystexxa |
| Horizon Therapeutics Plc | $43.98 | 2023 | Krystexxa |
| Convatec INC. | $26.68 | 2023 | |
| Kerecis Limited | $18.83 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Aroa Biosurgery Incorporated | $16.95 | 2025 | |
| Triad Life Sciences INC. | $16.40 | 2022 | |
| Averitas Pharma INC. | $15.82 | 2025 | Qutenza |
| Paragon 28, INC. | $12.68 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.